These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8176239)

  • 21. Immunization of retrovirus-transfected dendritic cells induces specific cytotoxic T lymphocytes for two distinct malarial peptides presented by Kd molecule.
    Hetttihewa LM
    Int Immunopharmacol; 2003 Oct; 3(10-11):1401-11. PubMed ID: 12946436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro induction of naive cytotoxic T lymphocytes with complexes of peptide and recombinant MHC class I molecules coated onto beads: role of TCR/ligand density.
    Motta I; Lone YC; Kourilsky P
    Eur J Immunol; 1998 Nov; 28(11):3685-95. PubMed ID: 9842911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccination with T cell receptor peptides primes anti-receptor cytotoxic T lymphocytes (CTL) and anergizes T cells specifically recognized by these CTL.
    Kuhröber A; Schirmbeck R; Reimann J
    Eur J Immunol; 1994 May; 24(5):1172-80. PubMed ID: 7514132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recognition of vaccinia virus-encoded major histocompatibility complex class I antigens by virus immune cytotoxic T cells is independent of the polymorphism of the peptide transporters.
    Lobigs M; Müllbacher A
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2676-80. PubMed ID: 8464875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of CD8+ cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells.
    Takahashi H; Nakagawa Y; Yokomuro K; Berzofsky JA
    Int Immunol; 1993 Aug; 5(8):849-57. PubMed ID: 8398980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peptide-specific cytotoxic T lymphocytes restricted by nonself major histocompatibility complex class I molecules: reagents for tumor immunotherapy.
    Sadovnikova E; Stauss HJ
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13114-8. PubMed ID: 8917553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A self-reactive class I-restricted T-cell response of H-2b mice to determinants of the V beta 8.2 domain of the T-cell receptor for antigen.
    Kuhröber A; Schirmbeck R; Reimann J
    Immunology; 1994 Dec; 83(4):532-9. PubMed ID: 7533132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes.
    Porgador A; Gilboa E
    J Exp Med; 1995 Jul; 182(1):255-60. PubMed ID: 7540653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of combinatorial peptide libraries to construct functional mimics of tumor epitopes recognized by MHC class I-restricted cytolytic T lymphocytes.
    Blake J; Johnston JV; Hellström KE; Marquardt H; Chen L
    J Exp Med; 1996 Jul; 184(1):121-30. PubMed ID: 8691125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An immunodominant epitope present in multiple class I MHC molecules and recognized by cytotoxic T lymphocytes.
    Mann DW; McLaughlin-Taylor E; Wallace RB; Forman J
    J Exp Med; 1988 Jul; 168(1):307-24. PubMed ID: 2456370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthetic peptides as antigens and competitors in recognition by H-2-restricted cytolytic T cells specific for HLA.
    Maryanski JL; Pala P; Cerottini JC; Corradin G
    J Exp Med; 1988 Apr; 167(4):1391-405. PubMed ID: 3128632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-time measurement of antigenic peptide binding to empty and preloaded single-chain major histocompatibility complex class I molecules.
    Ojcius DM; Godeau F; Abastado JP; Casanova JL; Kourilsky P
    Eur J Immunol; 1993 May; 23(5):1118-24. PubMed ID: 8477806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mapping of HLA epitopes recognized by H-2-restricted cytotoxic T lymphocytes specific for HLA using recombinant genes and synthetic peptides.
    Pala P; Corradin G; Strachan T; Sodoyer R; Jordan BR; Cerottini JC; Maryanski JL
    J Immunol; 1988 Feb; 140(3):871-7. PubMed ID: 2448379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Competition between unrelated peptides recognized by H-2-Kd restricted T cells.
    Pala P; Bodmer HC; Pemberton RM; Cerottini JC; Maryanski JL; Askonas BA
    J Immunol; 1988 Oct; 141(7):2289-94. PubMed ID: 2459204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxic T lymphocyte responses to wild-type and mutant mouse p53 peptides.
    Bertholet S; Iggo R; Corradin G
    Eur J Immunol; 1997 Mar; 27(3):798-801. PubMed ID: 9079825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A strong CD8+ T cell response is elicited using the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei together with the adjuvant QS-21: quantitative and phenotypic comparison with the vaccine model of irradiated sporozoites.
    Meraldi V; Romero JF; Kensil C; Corradin G
    Vaccine; 2005 Apr; 23(21):2801-12. PubMed ID: 15780728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel cytotoxic T-cell clone that exhibits differential modes of recognition in the proliferative and cytolytic phase.
    Kubota K
    Cell Immunol; 1986 Dec; 103(2):287-98. PubMed ID: 3492288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T cell receptor genes in a series of class I major histocompatibility complex-restricted cytotoxic T lymphocyte clones specific for a Plasmodium berghei nonapeptide: implications for T cell allelic exclusion and antigen-specific repertoire.
    Casanova JL; Romero P; Widmann C; Kourilsky P; Maryanski JL
    J Exp Med; 1991 Dec; 174(6):1371-83. PubMed ID: 1836010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intradomain H-2Kd/Dd recombinants define the same regions as crucial for recognition by alloreactive or major histocompatibility complex-restricted cytolytic T cells.
    Maryanski JL; Abastado JP; MacDonald HR; Kourilsky P
    Eur J Immunol; 1989 Jan; 19(1):193-6. PubMed ID: 2465901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.